|
楼主 |
发表于 2008-12-16 14:36:41
|
显示全部楼层
14-7-第七节 对类风湿炎发病机制的认识和研究新进展
对有关免疫球蛋白的糖基化异常和类风湿关节炎的关系,包括其糖链结构、分子构象、基因表达等基础研究,发病机制,临床发病和病情的相关性,以及其糖链特点可能在临床诊断中的应用等,已经进行了持续多年的研究。大量很有说服力的资料说明,IgG糖链结构与RA密切相关。但因类风湿关节炎的病因复杂,还缺乏确切反映人体RA的动物模型,其发病机制仍需进一步深入研究。近年,还观察到某些RA免疫球蛋白的糖链核心部位的岩藻糖化明显增加,但其临床意义还待阐明。最近,将K/BxN转基因小鼠的动物模型和人类的RA联系,通过对其关节滑膜的组织化学分析,观察到RA滑膜表面衬里细胞有高浓度的GPI(糖基化磷脂酰肌醇)沉积,说明GPI抗体可能参与关节的疾病。研究者认为这种动物模型中的现象也可能见于人类 RA,并对发展新型的关节介入治疗提供了思路。此外,有关RA的免疫学研究也十分活跃,尤其观察到CD4+T细胞与RA的炎症的发生和发展密切相关后,细胞免疫在RA中的病理作用目前受到很大关注,免疫球蛋白分子的糖基化改变与细胞免疫是否有关可能也应予以进一步探讨。 Q7 g& e" G, x" @" y
( 朱正美 )
4 C: W: u1 z: ^ o5 i: z 参考文献:
3 [$ p( q6 h8 w4 f8 g! q* }- E6 M% P7 p- r# N; b+ P+ a
燕秋,朱正美.免疫球蛋白的糖链与自身免疫疾病.生命的化学,1999. 19 (3) :118一120" u- `3 w: x% l$ a3 X6 Q- ]. l
" A0 _3 \6 D, z 张彦,范成明,朱正美.类风湿关节炎与免疫球蛋白糖基化.中华风湿病杂志,2001.5 (4):243一245 + B0 i1 R) J9 w x K/ n; l2 i0 g3 V
3 M" O0 k( P5 C1 K& U* z
张文利,燕秋,朱正美.免疫秋蛋白糖链结构异常和自身免疫性疾病.生物化学与生物物理进展,2001. 28 (3):348-352
: v$ x% B# f f/ ?/ d3 g0 D; C4 E; D R; l. T; ^
张彦,范成明,张晓萍,等.类风湿关节炎IgG糖链结构的变化在临床诊断中的价值.中华风湿病杂志,2002. 6(4):286一288 . z" d% t; [8 k0 j" b
# F/ Y" D$ f+ G' _% e Alavi A, Arden N, Spector TD et al. Immunoglobulin G Glycosylation and Clinical Outcome in Rheumatoid Arthritis During Pregnancy. J Rheumatology, 2000. 27(6):1380 % m- ^7 h; i$ J6 y V
$ q$ g1 |$ Z- u6 [ Axford JS. Glycosylation and rheumatic disease. Biochim Et
: {: M! I$ h2 g9 Z+ X! R: Q0 T5 b* Z$ U; P( c0 R3 M
Axford JS. The impact of glycobiology on medicine. Research Update, 2001.22(5) :237一239 , C0 j: M6 R$ K/ y5 ]" a
5 F8 I% o( x8 x* _, F5 Q* z, Y
Ayano Matsumoto, Kohdoh Shikata, Fujio Takeuchi, et al Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation. J Biochem.,2000. 128:621一628 5 M, B1 p/ o, }& {& F, ?" c
* V/ N ]% F( G4 I6 ^
Bond A, Alavi A, Axford J S, et al. The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA).juvenile chronic arthritis (JCA) and Sjogren's syndrome (SS). Clin Exp Immun.,1996. 105:99一103 : F# Q1 m( p! S4 d: @
+ f G7 e) _* E) R! P- L
BodmarrSmith M D, Anand A, Durand V, et al. Decreased expression of Fc gammaRIII (CD16) by gammadelta T cells in patients with rheumatoid arthritis. Immunology, 2000.99 (4):498一503
, s$ k3 D$ R7 W6 l
* X. l9 o0 _! f) h" ? Delves P J. The role of glycosylation in autoimmune diseases. Autoimmunity, 1998. 27: 239一253 3 b4 _, e( H: V. y
# O9 L& k2 I1 l+ h, G& W! Q; cDwek R A, Leouch A C, Wormald M R. Glycobiology: The function of sugar in the IgG molecule. J Anat.,1995. 187:279一292
) Y8 k# u; e. G% M2 i
5 j, A, B0 o& _ Kiyoshi F, Akira Kobata. Molecular immunology IgG galactosylation-its biological signficance and pathology. Molecular Immunology, 1991.28(12):1333一13408 W" u) |; f7 L
2 m$ ]* X. J3 O" L, P7 d
Kobata A. Function and pathology of the sugar chains of human immunoglobulin G. Glycobiology, 1990. 1(1):5一8 ' O' o" G+ [: p. c% N: m7 h
- K* c0 L) @3 o5 N Lee D M and W einblatt M E. Rheumatoid arthritis. Lancet, 2001.358: 903一911 $ B) d/ u) [: ?- T) e k
. B/ Z8 }" ?, z3 E' Z) i# c/ u Lang A K, Macht L M, Kirwan J R, et al. Ability of T cells from patients with rheumatoid arthritis to respond to immunoglobulin G. Immunology, 1999. 98:116一122 5 L3 w. R: Z. P/ V9 i' d% F
% h. Z* v4 O, L
Martin K, Talukder R, Hay F C, et al. Characterization of changes in IgG associated oligosaccharide profiles in rheumatoid arthritis, Psoriatic arthritis, and ankylosing spondylitis using fluorophore linked carbohydrate electrophoresis. J Rheumat., 2001.28(7):1531一1536 : j0 m7 I/ B, n/ E* `
8 v; H* f+ I; n7 x' q$ Z8 \ Miller-Blair D J, Tsuchiya N, Yamaguchi A, et al. Immunologic mechanisms in common rheumatologic diseases. ClinOrthop.,1996. 326:43一54 , o3 @! V& d& f( l. h* d: ^
& n3 l- D5 X( i6 S% A Parekh R B, Dwek R A, Sutton B J, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature, 1985. 316(6027):452一457
$ j5 O' X$ ]& t" _. z) j4 c D
( A3 e* L4 S. |# E) q& | Parekh R B, Dwek R A, Rademacher T W. Rheumatoid arthritis as a glycosylation disorder. British J Rheumatology.,1988. 27(supp1II) :162一169 7 U8 c7 |+ w- i
4 R6 N. Y3 ?! H; s" ]6 z3 A
Rudd P M and Dwek R A. Glycosylation: Hetrogeneity and the 3d structure of proteins Critical. Review in Biochemistry and Molecular Biology, 1997. 32(l):1一100 5 l( ]5 `8 n3 a6 H0 s6 P
/ H1 ^5 ~/ R0 X+ S# ]8 c Rudd P M, Elliot T, Cresswell P, et al. Glycosylation and the Immune System. Science, 2001.291: 2370一2376 ; p! f4 _1 s; [- P7 D
7 T$ }# R/ B) t9 ?
Rudd P M, Wormald M R and Dwek R A. Glycosylation and the Immune System. Trends in Glycoscience and Glycotechnology, 1999. 11(57):1一21 7 A0 ]! H1 T- k
" z, k7 Q; z7 M4 `* F( q$ q Wormald M R, Rudd P M, Harvey D J, et al. Variation in oligosaccharide--protein interactions in immunoglobulin G determination the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligasaccharides. Biochemistry, 1997.36:1370一138。# H1 y. }) f! [; a
+ w! k& B8 v2 [- V6 {0 C9 j9 ^$ C0 u Watson M, Rudd P M, Bland M, et al. Sugar printing rheumatic diseases. Arthritis and Rheumatism, 1999. 42 (8):1682一1690 |
|